RPL22P23

Across TCGA patient cohorts, RPL22P23 RNA expression is significantly associated with the go_rna of many other GO terms, with 6,323 significant associations in total. STAD shows the largest number of these associations.

The most reproducible RPL22P23-associated GO terms across cancer lineages are Peptidyl-lysine modification, Regulation of microtubule-based process, and RNA methylation. Each is linked with RPL22P23 in more than 15 cancer types. Because this analysis shows association rather than direction, both RPL22P23-to-partner and partner-to-RPL22P23 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Peptidyl-lysine modification grouped by RPL22P23-low versus RPL22P23-high in STAD.

RNA expression associated GO terms by consensus

Ranked by combined sampling and lineage consensus. X-score (RPL22P23→partner) and Y-score (partner→RPL22P23) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner GO term	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
STAD	Peptidyl-lysine modification →	+0.044	+0.246	<.001	<.001	3	16
ESCA	Regulation of microtubule-based process →	+0.037	+0.195	<.001	<.001	3	16
ESCA	RNA methylation →	+0.052	+0.254	<.001	<.001	3	16
ESCA	Obsolete DNA methylation →	+0.062	+0.271	<.001	<.001	3	16
STAD	IRES-dependent viral translational initiation →	+0.051	+0.235	<.001	<.001	3	16
ESCA	Macromolecule methylation →	+0.059	+0.298	<.001	<.001	3	16

Each partner links to its Q-omics profile. Showing the 6 strongest of 6,323 associations by consensus.

Peptidyl-lysine modification by RPL22P23 expression — STAD

Explore this box plot interactively →